FDA Grants Marketing Authorization to Banyan Biomarkers for the First Diagnostic Blood Test for Traumatic Brain Injury; Banyan BTI is the first in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussio

Press/Media

Period14 Feb 2018

Media coverage

2

Media coverage

  • TitleFDA Grants Marketing Authorization to Banyan Biomarkers for the First Diagnostic Blood Test for Traumatic Brain Injury; Banyan BTI is the first in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussio
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date14/02/18
    PersonsAndy Jagoda
  • TitleFDA Grants Marketing Authorization to Banyan Biomarkers for the First Diagnostic Blood Test for Traumatic Brain Injury; Banyan BTI is the first in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussio
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date14/02/18
    PersonsAndy Jagoda